ADVERTISEMENT

Nestle India Q1 Results Review— PL Capital Downgrade Rating To 'Hold', Cuts Target Price On Premium Valuations

PL Capital cut the target price and downgrades rating from Accumulate to Hold given headwinds in a dairy and nutrition and premium valuations.

<div class="paragraphs"><p>Nestle faces a big challenge in dairy given that a lot of domestic dairy players have much lower margin expectations and far competitive prices.</p><p>(photo: company fb page)</p></div>
Nestle faces a big challenge in dairy given that a lot of domestic dairy players have much lower margin expectations and far competitive prices.

(photo: company fb page)

Nestle posted a weak quarter with 5.9% sales growth and flattish Ebitda as margins declined 155 bps given impact of elevated commodity prices (coffee, cocoa, milk and palmoil), higher operational costs (expansion in capacity) and drag in sales from Milk products and nutrition.

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

PL Capital Report

We cut FY26/FY27 estimates of Nestle India Ltd. by 4.4/6.8% given-

  1. pressure on Milk Products and Nutrition category (~38% of sales) due to muted growth in dairy and rising competitive intensity in low growth infant nutrition and

  2. higher overheads /depreciation due to near doubling of gross block over last three years

Nestle posted a weak quarter with 5.9% sales growth and flattish Ebitda as margins declined 155 bps given impact of elevated commodity prices (coffee, cocoa, milk and palmoil), higher operational costs (expansion in capacity) and drag in sales from Milk products and nutrition.

We remain confident of doubledigit sales growth in Maggi, Nescafe (powder + RTD) and Chocolates (Wafers and milk chocolates). However, Maggi Noodles face rising competition from host of B2C brands in a fast-evolving category.

Nestle faces a big challenge in dairy given that a lot of domestic dairy players have much lower margin expectations and far competitive prices. Infant nutrition (Cerelac and Lectogen) has grown at low single digits in last decade and faces added competition from Danone in a high margin low growth segment.

Given ~11.7% PAT decline in 1Q, FY26 EPS growth is likely to be in low single digits and FY27 should likely show 10.3% EPS growth.

Even after assuming 11.5% EPS CAGR post FY26, the stock trades at 63xJune27 EPS, which limits any meaningful upside.

We cut the target price to Rs 2392 (Rs 2550 earlier) and rating from Accumulate to Hold given headwinds in a dairy and nutrition and premium valuations.

Click on the attachment to read the full report:

PL Capital Nestle Q1FY25 Results Review.pdf
Opinion
Nestle India Q1 Results: Profit Misses Estimates, Margin Contracts On Cost Pressures

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit